Glycopyrrolate Injection, Solution
Product Images NDC 76045-206

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 76045-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Gly03 0005 01)

FDA Label Image

Figure 1 (Gly03 0005 02)

Figure 1 (Gly03 0005 02)
This text appears to be a diagram or image labeling the different parts of a syringe. It includes labels for the plunger rod, label, syringe barrel, luer lock collar, and syringe tip cap.*
FDA Label Image

Figure 2 (Gly03 0005 03)

FDA Label Image

Figure 3 (Gly03 0005 04)

FDA Label Image

Figure (Gly03 0005 05)

Figure (Gly03 0005 05)
This appears to be a name and address, but without further context it is not possible to provide a useful description.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
This is a description for a medication called Glycopyrrolate. The medication is available in injection form with a concentration of 0.2 mg/mL. The injection can be used for Intramuscular or Intravenous use and comes in pre-filled single dose syringes. The unused portion needs to be discarded properly after use. Some unclear characters are present in the text.*
FDA Label Image

Package Label – Principal Display (Glycopyrrolate 1 mL Blister Pack Label)

FDA Label Image

Package Label – Principal Display – Glycopyrrolate 1 mL Syringe Label (Gly03 0005 08)

Package Label – Principal Display – Glycopyrrolate 1 mL Syringe Label (Gly03 0005 08)
This is a description of a medication produced by Fresenius Kabi. The medication is Glycopyrrolate and is available in single-dose form, either as 1 mL for intramuscular or intravenous use, or 0.5 mL. The concentration of the medication is 0.2 mg/mL, and it is only available with a prescription. The rest of the text appears to be unreadable characters.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Carton Panel)
This is a medication information sheet for Glycopyrrolate Injection, USP. It is a prescription drug for Intramuscular or Intravenous use only, containing 0.2mg/mL. The package contains 24 pre-filled single-dose syringes, and users are advised not to place the syringe on a sterile field. Unused portions should be discarded. The text also mentions "Simplist™ Ye" but without context, it is unclear what it refers to.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Blister Pack Label)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 1 mL Syringe Label)
This is a description of a medication that comes in a single dose of 1mL to be administered either through intramuscular (IM) or intravenous (IV) use. The text includes the brand name "Frasanius Kabl" and some identification numbers, but it is not clear what the medication is used for.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
This appears to be a medication label with information on a Glycopyrrolate injection. The injection contains 0.4 mg/2mL of the drug. The label also includes instructions for use, dosage, and how to properly discard any unused medication.*
FDA Label Image

Package Label – Principal Display (Glycopyrrolate 2 mL Blister Pack Label)

Package Label – Principal Display (Glycopyrrolate 2 mL Blister Pack Label)
This is a prescription drug that comes in a single dose syringe. It is preservative-free and contains Glycopyrrolate, which is used for injection. The syringe should not be placed on a sterile field and any unused portion should be discarded. It is meant for intramuscular or intravenous use only. The expiration date is not given.*
FDA Label Image

Package Label – Principal Display – Glycopyrrolate 2 mL Syringe Label (Gly03 0005 14)

Package Label – Principal Display – Glycopyrrolate 2 mL Syringe Label (Gly03 0005 14)
This is a prescription drug intended for intramuscular or intravenous use. It is a single-dose solution available in 2mL dose size. The drug's name is Glycopyrrolate 0.4mg/ml injection which is labeled USP. No further information is available due to incomplete text.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Carton Panel)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Carton Panel)
This is a medication called Glycopyrrolate, available in injection form with a concentration of 0.4 mg/2mL (0.2mg/mL). It is used for intramuscular or intravenous use only and comes in 24 prefilled 2mL single dose syringes. The instructions warn not to place the syringe on a sterile field and to discard any unused portion. There is also a brand name mentioned called Simplist™ from Fresenius.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Blister Pack Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Blister Pack Label)
This is a description of medication consisting of a single dose of 2mg Glycopyrrolate preserved with four preservatives. The medication is in a prefilled syringe and contains 0.4mg/2mL USP injection. The medication is meant for Intramuscular or Intravenous use and must be discarded once used. The medication should be stored at a temperature of 20 to 25°C (68° to 77°F).*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Glycopyrrolate 2 mL Syringe Label)
This is a description of a medication called Glycopyrrolate. It is an injection available in a single dose of 2 mL and is used either intramuscularly or intravenously. The medication requires a prescription. The strength of the medication is 0.2mg/ml. It is manufactured by Fresenius Kabi.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.